Surrey Heartlands

Joint Formulary & PAD

Ipratropium bromide - Hypersalivation in adults

You are here : Home > Formulary Search > Ipratropium bromide - Hypersalivation in adults

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Green (see narrative)
Formulations :
  • Nasal spray
  • Sublingual spray
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
BNF SPC
Un
Restrictions / Comments :
Important
Nasal spray applied sublingually. Off-label use.
 

Status 2

Green (see narrative)
Formulations :
  • Inhaler (Metered Dose)
  • Sublingual spray
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
BNF SPC
Un
Restrictions / Comments :
Important
Metered dose inhaler applied sublingually. Off-label use.

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Ipratropium bromide
Indication :
Hypersalivation in adults
Group Name :
Keywords :
excessive saliva, hypersialosis, drooling, sialorrhoea
Brand Names Include :
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0
Traffic Light Entries :
2

Other Indications

Below are listed other indications that Ipratropium bromide is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Hypersalivation in adults.

Committee Recommendations (1)

04 Dec 24 - Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The Surrey Heartlands Area Prescribing Committee agreed the traffic light status of this drug and indication as part of the Joint Formulary review.